Abstract:Rationale: Cationic nanocarriers present with well-known toxicities, including inflammatory toxicity, which limit their clinical application. How the cationic nanocarrier-induced inflammatory response is negatively regulated is unknown. Herein, we found that following a sublethal dose of cationic nanocarriers, the induced inflammatory response is characterized by early neutrophil infiltration and spontaneous resolution within 1 week. Methods: C57BL/6 mice were intravenously injected with a dosage of 1-100 mg/kg cationic DOTAP liposomes as well as other cationic materials. Cell necrosis was detected by flow cytometry. Release of mitochondrial DNA was quantified by qPCR via Taqman probes. Signal proteins were detected by Western blotting. PGE2 production in the supernatant was quantitated using an enzyme immunoassay (EIA). The infiltrated inflammatory cells were observed in WT mice, Ccr2-/- mice, Sting-/- mice and Tlr9-/- mice. Results: The early stage (24-48 h) inflammatory neutrophil infiltration was followed by an increasing percentage of monocytes; and, compared with WT mice, Ccr2-/- mice presented with more severe pulmonary inflammation. A previously uncharacterized population of regulatory monocytes expressing both inflammatory and immunosuppressive cytokines was identified in this model. The alteration in monocyte phenotype was directly induced by mtDNA release from cationic nanocarrier-induced necrotic cells via a STING- or TLR9-dependent pathway. Neutrophil activation was specifically inhibited by PGE2 from Ly6C+ inflammatory monocytes, and intravenous injections of dual-phenotype monocytes beneficially modified the immune response; this inhibitory effect was abolished after treatment with indomethacin. Moreover, we provide clear evidence that mitochondrial DNA activated Ly6C+ monocytes and increased PGE2 production through TLR9- or STING-mediated MAPK-NF-κB-COX2 pathways. Conclusion: Our findings suggest that Ly6C+ monocytes and mtDNA-induced Ly6C+ monocyte PGE2 production may be part of a feedback mechanism that contributes to the resolution of cationic nanocarrier-induced inflammatory toxicity and may have important implications for understanding nanoparticle biocompatibility and designing better, safer drug delivery systems.

Functionalized quantum dots induce proinflammatory responses in vitro: the role of terminal functional group-associated endocytic pathways.

Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation.

Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications

Peucedanum Praeruptorum Dunn Polysaccharides Regulate Macrophage Inflammatory Response Through TLR2/TLR4-mediated MAPK and NF-κB Pathways.

PEGylation of indium phosphide quantum dots prevents quantum dot mediated platelet activation

CdTe and CdTe@ZnS Quantum Dots Induce IL-1ß-mediated Inflammation and Pyroptosis in Microglia

Protein corona exacerbated inflammatory response in macrophages elicited by CdTe quantum dots

MPA-modified CdTe Quantum Dots Increased Interleukin-1Beta Secretion Through MyD88-dependent Toll-like Receptor Pathway and NLRP3 Inflammasome Activation in Microglia.

Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages

Low-dose cadmium telluride quantum dots trigger M1 polarization in macrophages through mTOR-mediated transcription factor EB activation

Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C+ monocytes

The Effect of Lipid Nanoparticle Pegylation on Neuroinflammatory Response in Mouse Brain

Influence of Polyethyleneglycol Modification on Phagocytic Uptake of Polymeric Nanoparticles Mediated by Immunoglobulin G and Complement Activation.

MoS2 Quantum Dots Alter Macrophage Plasticity and Induce Mitophagy to Attenuate Endothelial Barrier Dysfunctions

ROS-mediated NRF2/p-ERK1/2 signaling-involved mitophagy contributes to macrophages activation induced by CdTe quantum dots

CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation

The Role of NLRP3 Inflammasome Activation in the Neuroinflammatory Responses to Ag2Se Quantum Dots in Microglia.

Polylysine-derived carbon quantum dots modulate T lymphocyte responses for periodontitis treatment

PEGylated Graphene Oxide Elicits Strong Immunological Responses Despite Surface Passivation

YAP/TFRC/ALOXE3 Signaling is Involved in Ferroptosis and Neuroinflammation Triggered by Amino-Functionalized Graphene Quantum Dots

Surface Modification of Multiwall Carbon Nanotubes Determines the Pro-Inflammatory Outcome in Macrophage